NCT06565299

Brief Summary

The study is aimed to found out expressive speech disorders as a sign of neurocognitive development delay in children with congenital heart defects before and after surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
217

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

August 12, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

5.4 years

First QC Date

August 12, 2024

Last Update Submit

August 20, 2024

Conditions

Keywords

cognitive disodersheart disease

Outcome Measures

Primary Outcomes (1)

  • Neurocognitive status

    Monitoring before the cardiovascular operation and in postoperative period (in 1 and 2 years). Assessment of speech disorders, short-term and long-term memory impairments.

    2 years

Study Arms (2)

Group 1

Children with family anamnesis confounding factorss, such as family composition, living conditions, conflict families (members of family suffering from any type of addiction, prisoned members of family, conflicts in front of a child's eyes).

Procedure: Cardiovascular surgery with cardiopulmonary bypass

Group 2

without family anamnesis confounding factors

Procedure: Cardiovascular surgery with cardiopulmonary bypass

Interventions

Cardiovascular surgery about congenital heart defects with cardiopulmonary bypass

Group 1Group 2

Eligibility Criteria

Age5 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

5-7 years old children with congenital heart defects bofore abd after cardiovascular operation with cardiopulmonary bypass

You may qualify if:

  • children with congenital heart disease that required total correction using cardiopulmonary bypass

You may not qualify if:

  • patients with heart disease requiring palliative or endovascular correction, as well as children with chromosomal and genetic diseases (determined by karyotyping)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aleksandra Aeksandrovna Rumiantseva

Kemerovo, Kemerovo Oblast, 650066, Russia

Location

MeSH Terms

Conditions

Cognition DisordersHeart Diseases

Interventions

Cardiovascular Surgical ProceduresCardiopulmonary Bypass

Condition Hierarchy (Ancestors)

Neurocognitive DisordersMental DisordersCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeExtracorporeal Circulation

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Anesthesiology

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 21, 2024

Study Start

March 1, 2019

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

August 21, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations